Jane Huang Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Jane Huang is CMO, Hematology of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2021, when has been sold 1,500 shares (American Depositary Shares) at a price of $279.11 per share, resulting in proceeds of $418,665. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jane Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2021
SELL
Open market or private sale
$418,665 $279.11 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Dec 14 2021
BUY
Exercise of conversion of derivative security
$179,940 $119.96 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Dec 01 2021
SELL
Open market or private sale
$377,525 $359.89 p/Share
1,049 Reduced 100.0%
0 American Depositary Sh...
Nov 30 2021
BUY
Grant, award, or other acquisition
-
1,049 Added 50.0%
1,049 American Depositary Sh...
Nov 30 2021
BUY
Grant, award, or other acquisition
-
14,820 Added 8.47%
160,055 Ordinary Shares
Nov 17 2021
SELL
Open market or private sale
$572,055 $381.37 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Nov 17 2021
BUY
Exercise of conversion of derivative security
$179,940 $119.96 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Oct 19 2021
SELL
Open market or private sale
$558,585 $372.39 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Oct 19 2021
BUY
Exercise of conversion of derivative security
$179,940 $119.96 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Sep 20 2021
SELL
Open market or private sale
$2,399,760 $399.96 p/Share
6,000 Reduced 100.0%
0 American Depositary Sh...
Sep 20 2021
BUY
Exercise of conversion of derivative security
$719,760 $119.96 p/Share
6,000 Added 50.0%
6,000 American Depositary Sh...
Sep 13 2021
SELL
Open market or private sale
$4,637,393 $359.46 p/Share
12,901 Reduced 100.0%
0 American Depositary Sh...
Sep 02 2021
SELL
Open market or private sale
$178,313 $327.18 p/Share
545 Reduced 100.0%
0 American Depositary Sh...
Sep 01 2021
SELL
Open market or private sale
$168,307 $310.53 p/Share
542 Reduced 100.0%
0 American Depositary Sh...
Sep 01 2021
BUY
Grant, award, or other acquisition
-
7,124 Added 2.23%
312,948 Ordinary Shares
Sep 01 2021
BUY
Grant, award, or other acquisition
-
545 Added 50.0%
545 American Depositary Sh...
Aug 31 2021
BUY
Grant, award, or other acquisition
-
7,163 Added 2.29%
305,824 Ordinary Shares
Aug 31 2021
BUY
Grant, award, or other acquisition
-
542 Added 50.0%
542 American Depositary Sh...
Jul 15 2021
SELL
Open market or private sale
$6,997,410 $333.21 p/Share
21,000 Reduced 100.0%
0 American Depositary Sh...
Jul 15 2021
BUY
Exercise of conversion of derivative security
$3,183,600 $151.6 p/Share
21,000 Added 50.0%
21,000 American Depositary Sh...
Jun 29 2021
SELL
Open market or private sale
$528,270 $352.18 p/Share
1,500 Reduced 100.0%
0 American Depositary Sh...
Jun 29 2021
BUY
Exercise of conversion of derivative security
$44,235 $29.49 p/Share
1,500 Added 50.0%
1,500 American Depositary Sh...
Jun 28 2021
SELL
Open market or private sale
$155,125 $365.0 p/Share
425 Reduced 100.0%
0 American Depositary Sh...
Jun 18 2021
SELL
Open market or private sale
$152,735 $325.66 p/Share
469 Reduced 100.0%
0 American Depositary Sh...
Jun 16 2021
BUY
Grant, award, or other acquisition
-
25,350 Added 7.69%
304,186 Ordinary Shares

Also insider at

TARA
Protara Therapeutics, Inc. Healthcare
PRLD
Prelude Therapeutics Inc Healthcare
President, CMO
JH

Jane Huang

CMO, Hematology
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE